BRIEF published on 07/29/2025 at 22:13, 1 year 1 month ago DBV Technologies Posts Financial Results for H1 2025 Research And Development Operating Income DBV Technologies Viaskin Peanut Financial Results 2025
BRIEF published on 07/29/2025 at 22:13, 1 year 1 month ago DBV Technologies publie ses résultats financiers pour le premier semestre 2025 Recherche Et Développement Résultat D'exploitation DBV Technologies Viaskin Peanut Résultats Financiers 2025
PRESS RELEASE published on 07/29/2025 at 22:08, 1 year 1 month ago DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results DBV Technologies reports financial results for Q2 and first half 2025, with operating income at $2.2M and net loss of $69.0M. Company focuses on food allergy treatment using Viaskin technology Financial Results DBV Technologies Food Allergies Q2 2025 Viaskin Technology
PRESS RELEASE published on 07/29/2025 at 22:08, 1 year 1 month ago DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025 DBV Technologies publie ses résultats financiers du 2ème trimestre et 1er semestre 2025. Analyse des produits, charges, pertes, trésorerie et perspectives de la société biopharmaceutique Résultats Financiers Trésorerie Pertes Trimestre DBV Technologies
BRIEF published on 07/28/2025 at 22:35, 1 year 1 month ago DBV Technologies Releases Half-Year Liquidity Contract Report Liquidity Contract Financial Report ODDO BHF Stock Transactions DBV Technologies
BRIEF published on 07/28/2025 at 22:35, 1 year 1 month ago DBV Technologies publie son rapport semestriel sur les contrats de liquidité Contrat De Liquidité ODDO BHF Rapport Financier Transactions Sur Actions DBV Technologies
PRESS RELEASE published on 07/28/2025 at 22:30, 1 year 1 month ago Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF DBV Technologies issues Half-Year report on liquidity contract with ODDO BHF, including transaction details and assets overview Liquidity Contract Half-year Report ODDO BHF Biopharmaceutical DBV Technologies
BRIEF published on 07/22/2025 at 22:35, 1 year 2 months ago DBV Technologies nomme James Briggs Directeur des Ressources Humaines Ressources Humaines Biopharmaceutique Commercialisation DBV Technologies James Briggs
BRIEF published on 07/22/2025 at 22:35, 1 year 2 months ago DBV Technologies Appoints James Briggs as Chief Human Resources Officer Marketing Biopharmaceuticals Human Resources DBV Technologies James Briggs
Published on 09/25/2026 at 22:15, 9 minutes ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 4 hours 54 minutes ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 7 hours 24 minutes ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/25/2026 at 14:00, 8 hours 24 minutes ago Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich
Published on 09/25/2026 at 13:00, 9 hours 24 minutes ago Core Silver Announces Grant of Stock Options
Published on 09/25/2026 at 18:30, 3 hours 54 minutes ago 029 Group SE: Publication of Half-Year Report 2026
Published on 09/25/2026 at 18:00, 4 hours 24 minutes ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 31.08.26
Published on 09/25/2026 at 17:30, 4 hours 54 minutes ago GEVELOT S.A.: Weekly declaration of share buybacks – 09/25/2026 (French only)
Published on 09/25/2026 at 17:30, 4 hours 54 minutes ago GEVELOT S.A.: Déclaration hebdomadaire de rachat d'actions 25/09/2026
Published on 09/25/2026 at 17:45, 4 hours 39 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 4 hours 44 minutes ago Availability of the 2026 half-year financial report
Published on 09/25/2026 at 17:40, 4 hours 44 minutes ago Mise à disposition du rapport financier semestriel 2026
